Libella Gene Therapeutics
- Company typePrivate
- Founded-
- HeadquartersManhattan, United States
- Headcount—
- GTM typeB2C
- OfferingServices
Libella Gene Therapeutics firmographics
Firmographics- Name
- Libella Gene Therapeutics
- Website
- https://libellagenetherapeutics.com
- Company type
- Private
- Ownership category
- akta.pro rank
Libella Gene Therapeutics industry classification
Industry- Product category
- Gene Therapy
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Gene Therapy for Rare/Monogenic Diseases (HLAAACAE)
Keywords
Where Libella Gene Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Manhattan
- HQ country
- United States
- HQ region
- North America
Markets served
Libella Gene Therapeutics business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Libella Gene Therapeutics product offering
Product offeringCore offering
Libella Gene Therapeutics develops gene therapy treatments aimed at addressing diseases through genetic-medicine interventions. The company has obtained full regulatory approval in Vanuatu, enabling it to deliver therapeutic gene-based products within that jurisdiction as a for-profit private entity.
Differentiator
Problem solved
Functional benefit
Companies that use Libella Gene Therapeutics
Customer profileIdeal customer profiles1 record
Libella Gene Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Libella Gene Therapeutics partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Libella Gene Therapeutics competitors and assessment
Company assessmentMarket position
Competitive moat1 record
Key risks4 records
Key highlights4 records
Customer concentration
Libella Gene Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Libella Gene Therapeutics leadership team
Management profileNumber of profiles
Profiles1 record
Libella Gene Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Libella Gene Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Libella Gene Therapeutics
What does Libella Gene Therapeutics do?
Libella Gene Therapeutics develops gene therapy treatments aimed at addressing diseases through genetic-medicine interventions. The company has obtained full regulatory approval in Vanuatu, enabling it to deliver therapeutic gene-based products within that jurisdiction as a for-profit private entity.
When was Libella Gene Therapeutics founded?
Libella Gene Therapeutics was founded in -1.
Where is Libella Gene Therapeutics based?
Libella Gene Therapeutics is headquartered in Manhattan, United States, in the North America region.
Does Libella Gene Therapeutics have an API?
No public API is recorded for Libella Gene Therapeutics.
What industry is Libella Gene Therapeutics in?
Libella Gene Therapeutics's product category is Gene Therapy. Its primary akta.pro industry code is HLAAACAE, Gene Therapy for Rare/Monogenic Diseases. Its NAICS code is 325414 and its SIC code is 2834.